Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berit Grevstad

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Cochrane Database of Systematic Reviews|April 8, 2014
Nitazoxanide for chronic hepatitis CKristiana Nikolova, Christian Gluud, Berit Grevstad, et al.
BMJ Open|August 21, 2014
Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trialsPernille Kähler, Berit Grevstad, Thomas Almdal, et al.
Journal of Immunological Methods|October 5, 2010
Development of standard operating procedures to obtain longitudinal vaginal specimens from nulliparous rabbits as part of HIV vaccine mucosal immunogenicity studiesVictor Raúl Gómez Román, Lasse Vinner, Berit Grevstad, et al.
The Journal of Infectious Diseases|July 5, 2005
Differential induction of immunoglobulin G to Plasmodium falciparum variant surface antigens during the transmission season in Daraweesh, SudanMorten A Nielsen, Berit Grevstad, Thoraya M E A-Elgadir, et al.
Plos One|September 12, 2013
Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination modelLeo Heyndrickx, Guillaume Stewart-Jones, Marianne Jansson, et al.
Journal of Translational Medicine|July 10, 2013
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolateMaria Luisa Visciano, Maria Tagliamonte, Guillaume Stewart-Jones, et al.
Infection and Immunity|May 25, 2004
Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigensMorten A Nielsen, Lasse S Vestergaard, John Lusingu, et al.
Vaccines|September 8, 2015
Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus MacaquesMarie Borggren, Lasse Vinner, Betina Skovgaard Andresen, et al.
BMJ (Clinical Research Ed.)|January 9, 2015
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trialSimon Hyttel-Sorensen, Adelina Pellicer, Thomas Alderliesten, et al.
Trials|June 21, 2013
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trialSimon Hyttel-Sorensen, Topun Austin, Frank van Bel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Cochrane Database of Systematic Reviews|April 8, 2014
Nitazoxanide for chronic hepatitis CKristiana Nikolova, Christian Gluud, Berit Grevstad, et al.
BMJ Open|August 21, 2014
Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trialsPernille Kähler, Berit Grevstad, Thomas Almdal, et al.
Journal of Immunological Methods|October 5, 2010
Development of standard operating procedures to obtain longitudinal vaginal specimens from nulliparous rabbits as part of HIV vaccine mucosal immunogenicity studiesVictor Raúl Gómez Román, Lasse Vinner, Berit Grevstad, et al.
The Journal of Infectious Diseases|July 5, 2005
Differential induction of immunoglobulin G to Plasmodium falciparum variant surface antigens during the transmission season in Daraweesh, SudanMorten A Nielsen, Berit Grevstad, Thoraya M E A-Elgadir, et al.
Plos One|September 12, 2013
Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination modelLeo Heyndrickx, Guillaume Stewart-Jones, Marianne Jansson, et al.
Journal of Translational Medicine|July 10, 2013
Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolateMaria Luisa Visciano, Maria Tagliamonte, Guillaume Stewart-Jones, et al.
Infection and Immunity|May 25, 2004
Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigensMorten A Nielsen, Lasse S Vestergaard, John Lusingu, et al.
Vaccines|September 8, 2015
Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus MacaquesMarie Borggren, Lasse Vinner, Betina Skovgaard Andresen, et al.
BMJ (Clinical Research Ed.)|January 9, 2015
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trialSimon Hyttel-Sorensen, Adelina Pellicer, Thomas Alderliesten, et al.
Trials|June 21, 2013
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trialSimon Hyttel-Sorensen, Topun Austin, Frank van Bel, et al.
Pageof 1